The largest database of trusted experimental protocols

Penicillin rpmi media

Manufactured by Thermo Fisher Scientific
Sourced in United States

Penicillin RPMI media is a cell culture medium formulated for the growth of a variety of cell types. It contains the antibiotic penicillin to prevent bacterial contamination. The core function of this product is to provide a nutrient-rich environment to support the proliferation of cells in in vitro experiments.

Automatically generated - may contain errors

2 protocols using penicillin rpmi media

1

Bone Marrow Transplant and SRBC Immunization

Check if the same lab product or an alternative is used in the 5 most similar protocols
Recipient C57BL/6 Rag1−/− mice 8–12 weeks old were irradiated with 425 cGy using an X-RAD 320 Biological Irradiator (Precision X-Ray, North Branford, CT, USA). Donor bone marrow was aspirated from femurs, humeri and tibia into B-cell medium comprising RPMI (Gibco, Carlsbad, CA, USA) with 10% heat-inactivated foetal calf serum (Gibco), 2 mMl-glutamine and 100 U/ml penicillin RPMI media (Gibco). At 15 h after irradiation, recipient mice were transplanted with an intravenous injection of 5–10 × 106 bone marrow cells, comprising a mixture of 50% from CD45.1 congenic C57BL/6 mice and 50% from C57BL6 (CD45.2) mice that were either Lrba−/− or Lrba+/+.
Unmanipulated mice 8 weeks old, and bone marrow chimeras 8 weeks after marrow transplantation, were immunised with 2 × 108 SRBCs given intravenously.
+ Open protocol
+ Expand
2

Bone Marrow Transplantation in Transgenic Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
Recipient mice of 8 to 12 wk of age were lethally irradiated (2 × 425 cGy) using an X-RAD 320 Biological Irradiator (Precision X-Ray). Femoral, humeral, and tibial bone marrow cells were aspirated into RPMI (Gibco) with 10% heat-inactivated fetal calf serum (FCS) (Gibco), 2 mM l-glutamine, and 100 U/mL penicillin RPMI media (Gibco). Fifteen hours after irradiation, recipient mice were transplanted with an i.v. injection of 5 to 10 × 106 bone marrow cells. For mHEL3X transgenic (CD45.2+) recipients, injected bone marrow cells were 80% of SWHEL.Rag1−/− (CD45.1+) origin and 20% of mHEL3X transgenic (CD45.2+) origin. Control nontransgenic mice were reconstituted with less (45%) SWHEL.Rag1−/− (CD45.1+) and more (55%) wild-type (CD45.2+) bone marrow, so that comparable frequencies of anti-HEL B cells in the transitional subset of the spleen were obtained in chimeras irrespective of self-antigen (mHEL3X) expression, as described previously (38 (link)). Chimeras were analyzed 8 to 14 wk after reconstitution.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!